- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02493023
Automatic CT-to-patient Registration During Navigated Bronchoscopy and EBUS
March 29, 2016 updated by: St. Olavs Hospital
Assessment of a Novel, Fast and Automatic CT-to-patient Registration Method During Navigated Bronchoscopy and Endobronchial Ultrasound Bronchoscopy (EBUS)
Bronchoscopic diagnosis and staging of lung cancer must be gentle and quick, and requires optimal sampling precision.Electromagnetic navigation systems are promising for intraoperative guiding based on maps made of preoperative CT images.
Navigation accuracy depends largely on correct alignment of preoperative images to the patient´s position in space during endoscopy.
In this study, the accuracy of a new fast and automatic image-to-patient registration method during the initial phase of bronchoscopy is assessed in patients referred for lung cancer investigation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is an accuracy study of a new automatic CT-to-patient registration technique for bronchoscopy and endobronchial ultrasound bronchoscopy (EBUS).
An in-house research and development navigation platform displays the intraoperative position of the endoscope inside the airways, and shows its exact position in three-dimensional (3D) maps made from the patients' own preoperative CT images.
The navigation system is used for acquiring position data from a bronchoscope or EBUS-scope (same sort of output data acquired from both endoscopes in this study) equipped with a position sensor for electromagnetic tracking.
From intraoperative position data, the accuracy of the image-to-patient registration and the navigation system accuracy can be calculated.
When targeting a certain lymph node or tumor for sampling, the pulmonologist can use electromagnetic navigation combined with preoperative CT images to navigate directly, precisely and accurately to the area of interest.
Functional systems for navigated bronchoscopy and EBUS may therefore lead to considerable improvements in lung cancer diagnosis and mediastinal staging.
Study Type
Interventional
Enrollment (Actual)
26
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Trondheim, Norway
- Department of Thoracic Medicine, St Olavs Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- referred to thoracic department St Olavs Hospital due to suspicion of lung cancer
- informed consent
Exclusion Criteria:
- pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: navigated bronchoscopy
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
endoscope position (measured in millimetres from origo in the x, y and z-plane) in 3 dimensional maps from preoperative CT images
Time Frame: 48 hours
|
intraoperative positional data of bronchoscope or endobronchial ultrasound scope (EBUS) measured and stored in navigation system software, used for registration and navigation system accuracy calculations
|
48 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
duration of procedure
Time Frame: 48 hours
|
time from first entry of endoscope through vocal cords to final withdrawal of endoscope
|
48 hours
|
adverse events
Time Frame: 48 hours
|
procedure related adverse events or unexpected incidents registrated
|
48 hours
|
patient reported satisfaction
Time Frame: 48 hours
|
enquiry on patients´own experience 2 hours after end of navigated bronchoscopy/EBUS procedure
|
48 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Toril A Nagelhus Hernes, prof, Department of Circulation and Imaging
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2011
Primary Completion (Actual)
August 1, 2015
Study Completion (Actual)
August 1, 2015
Study Registration Dates
First Submitted
July 1, 2015
First Submitted That Met QC Criteria
July 6, 2015
First Posted (Estimate)
July 9, 2015
Study Record Updates
Last Update Posted (Estimate)
March 30, 2016
Last Update Submitted That Met QC Criteria
March 29, 2016
Last Verified
March 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2010/3385
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bronchial Neoplasms
-
South Valley UniversityCompletedBronchial Neoplasm Benign
-
St. Olavs HospitalNorwegian University of Science and Technology; SINTEF Health ResearchCompleted
-
Norwegian University of Science and TechnologySt. Olavs Hospital; SINTEF Health ResearchSuspended
-
University of CologneCompletedBronchial NeoplasmsSpain, Germany
-
Groupe Hospitalier Paris Saint JosephCompleted
-
RENAULT Patrick AldoCompleted
-
Centre Hospitalier Universitaire DijonUnknown
-
Centre Hospitalier de PAUCompleted
-
University Hospital, Strasbourg, FranceCompletedBronchial CancerFrance
-
Centre Hospitalier Intercommunal CreteilCompleted
Clinical Trials on navigated bronchoscopy
-
St. Olavs HospitalNorwegian University of Science and Technology; SINTEF Health ResearchCompleted
-
The University of Texas Health Science Center at...The University of Texas Health Science Center, Houston; University of California... and other collaboratorsCompletedBreast Cancer
-
Aesculap AGTerminatedOsteoarthritis | Rheumatoid Arthritis | Post-traumatic ArthritisGermany
-
University of California, San FranciscoNational Institute on Aging (NIA); University of Nebraska; Centers for Medicare...CompletedDementia | Alzheimer Disease | Lewy Body Disease | Dementia, Vascular | Frontotemporal Lobar Degeneration | Memory Disorders
-
Helsinki University Central HospitalCompletedCentral Post Stroke Pain
-
University Health Network, TorontoTerminatedLung Cancer | Esophagus CancerCanada
-
University of California, San FranciscoNational Institute on Aging (NIA); University of Nebraska; Centers for Medicare...CompletedDementia | Alzheimer Disease | Lewy Body Disease | Dementia, Vascular | Frontotemporal Lobar Degeneration | Memory DisordersUnited States
-
Medical University of GrazCompleted
-
Ottawa Hospital Research InstituteFormusLabNot yet recruitingOsteoarthritis, Hip